









Mercado
/
Acciones
/
nasdaq-holx
/

Hologic Inc

HOLX

74.810USD

+0.110+0.15%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

16.69BCap. mercado

30.83P/E TTM



Hologic Inc

74.810

+0.110+0.15%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Hologic Inc Compañía

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Información de Hologic Inc



Símbolo de cotizaciónHOLX

Nombre de la empresaHologic Inc

Fecha de salida a bolsaMar 01, 1990

Director ejecutivoMacmillan (Stephen P)

Número de empleados7070

Tipo de seguridadOrdinary Share

Fin del año fiscalMar 01

Dirección250 Campus Drive

CiudadMARLBOROUGH

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal01752

Teléfono15082632900

Sitio Webhttps://www.hologic.com/

Símbolo de cotizaciónHOLX

Fecha de salida a bolsaMar 01, 1990

Director ejecutivoMacmillan (Stephen P)

Ejecutivos de Hologic Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Christiana Stamoulis

Independent Director

45.47K

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+15736.00%

Mr. Essex D. Mitchell

Chief Operating Officer

20.34K

+84.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.51K

-90.00%

Mr. Charles J. Dockendorff, CPA

Independent Director

16.94K

Ms. Diana De Walt

Senior Vice President - Human Resources

7.60K

-4416.00%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

7.40K

Ms. Nanaz Mohtashami

Independent Director

2.32K

Ms. Stacey D. Stewart

Independent Director

1.73K

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Christiana Stamoulis

Independent Director

45.47K

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+15736.00%

Mr. Essex D. Mitchell

Chief Operating Officer

20.34K

+84.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.51K

-90.00%

Mr. Charles J. Dockendorff, CPA

Independent Director

16.94K

Ms. Diana De Walt

Senior Vice President - Human Resources

7.60K

-4416.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

2.62B

63.84%

Service

825.50M

20.13%

Capital equipment, components and software

638.40M

15.57%

Other

18.90M

0.46%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

3.05B

74.33%

Europe

591.00M

14.41%

Asia

243.30M

5.93%

Rest of World

218.30M

5.32%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

2.62B

63.84%

Service

825.50M

20.13%

Capital equipment, components and software

638.40M

15.57%

Other

18.90M

0.46%

Estadísticas de accionistas

Actualizado: sáb., 31 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

11.64%

T. Rowe Price Investment Management, Inc.

9.65%

BlackRock Institutional Trust Company, N.A.

5.57%

Manulife Investment Management (North America) Limited

4.68%

State Street Investment Management (US)

4.47%

Otro

63.99%

Accionistas

Proporción

The Vanguard Group, Inc.

11.64%

T. Rowe Price Investment Management, Inc.

9.65%

BlackRock Institutional Trust Company, N.A.

5.57%

Manulife Investment Management (North America) Limited

4.68%

State Street Investment Management (US)

4.47%

Otro

63.99%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

55.62%

Investment Advisor/Hedge Fund

27.52%

Hedge Fund

7.07%

Research Firm

2.40%

Pension Fund

1.97%

Bank and Trust

1.54%

Sovereign Wealth Fund

1.26%

Individual Investor

0.83%

Family Office

0.05%

Otro

1.74%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1621

217.54M

97.44%

-28.64M

2025Q3

1587

223.55M

100.44%

-14.31M

2025Q2

1594

230.47M

103.62%

-13.07M

2025Q1

1635

231.71M

103.94%

-14.47M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

26.11M

11.71%

-587.96K

-2.20%

Sep 30, 2025

T. Rowe Price Investment Management, Inc.

21.55M

9.66%

-2.53M

-10.52%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

12.44M

5.57%

-516.22K

-3.99%

Sep 30, 2025

Manulife Investment Management (North America) Limited

10.45M

4.68%

-572.01K

-5.19%

Sep 30, 2025

State Street Investment Management (US)

9.98M

4.47%

-122.10K

-1.21%

Sep 30, 2025

Geode Capital Management, L.L.C.

5.90M

2.64%

+68.67K

+1.18%

Sep 30, 2025

Victory Capital Management Inc.

5.47M

2.45%

-28.86K

-0.52%

Sep 30, 2025

Invesco Advisers, Inc.

4.36M

1.96%

+35.56K

+0.82%

Sep 30, 2025

Black Creek Investment Management, Inc.

3.74M

1.68%

-284.48K

-7.06%

Sep 30, 2025

Citadel Advisors LLC

3.00M

1.34%

-712.33K

-19.21%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

First Trust Nasdaq Lux Digi Health Solutions ETF

4.41%

LeaderShares AlphaFactor Tactical Focused ETF

3.17%

John Hancock Fundamental All Cap Core ETF

3.15%

AltShares Event-Driven ETF

2.95%

ProShares Merger ETF

2.78%

First Trust Indxx Medical Devices ETF

2.19%

Strategas Global Policy Opportunities ETF

2.08%

State Street SPDR S&P Health Care Equipment ETF

2.02%

iShares U.S. Medical Devices ETF

1.95%

Brandes US Small-Mid Cap Value ETF

1.94%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción4.41%

LeaderShares AlphaFactor Tactical Focused ETF

Proporción3.17%

John Hancock Fundamental All Cap Core ETF

Proporción3.15%

AltShares Event-Driven ETF

Proporción2.95%

ProShares Merger ETF

Proporción2.78%

First Trust Indxx Medical Devices ETF

Proporción2.19%

Strategas Global Policy Opportunities ETF

Proporción2.08%

State Street SPDR S&P Health Care Equipment ETF

Proporción2.02%

iShares U.S. Medical Devices ETF

Proporción1.95%

Brandes US Small-Mid Cap Value ETF

Proporción1.94%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

